Nanotechnology boosts immune response at tumour site in mice

Source: Drug Target Review, December 2021

The new nanotechnology left six of 10 mice with lymphoma tumour-free and was effective in melanoma when combined with existing drugs.

Scientists at Ohio State University, US, have boosted activation of T cells inside tumours in a way that improved their interactions with an antibody therapy currently being tested in clinical trials. The team stated that the nanotechnology may help enhance immunotherapy treatments in advanced stages of the disease.

READ THE ORIGINAL FULL ARTICLE